Boundless Bio has filed a notice of an exempt offering of securities to raise $100 Million in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Boundless Bio is raising $100,000,000.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Zachary Hornby played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Boundless Bio
Boundless Bio is discovering and developing novel cancer therapeutics based on the role of extrachromosomal DNA (ecDNA) in driving tumorigenesis, resistance and recurrence. When DNA in cancer cells comes off chromosomes, extrachromosomal DNA (ecDNA), it becomes unbound and unwound, thereby enabling numerous copies of cancer-causing genes, driving cancer cells to grow and allowing them to resist treatment. At Boundless Bio, we are counterattacking this ecDNA phenomenon with boundless innovation and boundless energy to develop powerful new cancer medicines that eliminate cancer cells ability to employ ecDNA to survive. Our Culture: At Boundless, youll experience what it means to be out in front of the wave. Our unprecedented science takes us to new shores, and our team navigates the best breaks. Were leaders in our field, and were dedicated to the cause of understanding and treating intractable cancers. Every employee at Boundless makes an unbridled impact on our capabilities and our culture. Well help you expand your abilities and defy your bounds by providing meaningful work and unbounded opportunities. Career development is essential at Boundless. Were all in on this fight against cancer collaboration is requisite to our success. We have a team of people who ask, offer, and accept help without regard for ego. We know that receiving support is energizing, and giving help is fulfilling. We are inspired by the patients who are reliant upon our success. At Boundless, were all in. We are unbound by convention, bound to save lives.
To learn more about Boundless Bio, visit http://boundlessbio.com/
Contact:
Zachary Hornby, President and Chief Executive Officer
858-766-9912
https://www.linkedin.com/in/zacharyhornby/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.